In this webinar, our panelist will discuss emerging tools and strategies for the characterization of stem cells derived from heterogeneous populations and applications of this model system for drug discovery.
Cancer stem cells represent an attractive model for in vitro tumor modeling, especially for closer, physiological screening of new anticancer compounds. Although much progress has been made in culturing cancer stem cells, technical challenges persist in the identification and characterization of cell types in a heterogeneous cellular population. In this webinar, our panelist will discuss emerging tools and strategies for the characterization of stem cells derived from heterogeneous populations and applications of this model system for drug discovery. Following the presentation, attendees will have an opportunity to ask questions concerning their specific applications and receive answers in real-time.
Topics to be covered:
- An overview of 2-D versus 3-D cancer stem cell culture models
- Screening of anticancer drug treatments using a cancer stem cell-derived model
- Approaches for characterizing and verifying cell type over time based on intracellular biomarker detection
Meet the Speaker:
Dr. Christian D. Muller
Faculty Member
Faculté de Pharmacie...
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
